Marilyn Brachman Hoffman Foundation

A donor's foundation that channels its entire scientific effort into understanding Multiple Chemical Sensitivity, funding rigorous multiyear research on a condition much of medicine still overlooks.

6named by peers

Financial profile

Marilyn Brachman Hoffman Foundation · EIN 75-2761459 · 501(c)(3)

Fiscal yearTotal revenueContributionsProgram servicesTotal expensesNet assetsYear end
FY2023$1,815,773$2,681,617$47,528,828Dec 2023
FY2022$1,456,469$2,454,710$48,503,597Dec 2022
FY2021$5,487,747$2,469,907$49,209,375Dec 2021
FY2020$1,634,257$1,815,865$46,149,982Dec 2020
FY2019$43,827,481$1,622,032$46,331,590Dec 2019
FY2015$1,100,014$1,141,892$68,166Dec 2015

Figures exactly as reported. A blank cell was blank on the form. The fiscal year links to the filing.

Something wrong here? Tell us what we missed.

Peer societies

Five societies Marilyn Brachman Hoffman Foundation is read alongside.

Who backs MBHF

No public supporter list found as of September 2026.

Something wrong here? Tell us what we missed.

Who backs Marilyn Brachman Hoffman Foundation's peers, but not Marilyn Brachman Hoffman Foundation

Companies named publicly by at least one of Marilyn Brachman Hoffman Foundation's five peer societies, and not found in Marilyn Brachman Hoffman Foundation's reviewed public records.

CompanyGJCFPeers
AlexionIndustry Council1 of 1
Amgen Rare DiseaseIndustry Council1 of 1
BiogenEmeritus Members1 of 1
GenentechIndustry Council1 of 1
NovartisEmeritus Members1 of 1
OpexaEmeritus Members1 of 1

Something wrong here? Tell us what we missed.

The outside view

A donor's foundation that channels its entire scientific effort into understanding Multiple Chemical Sensitivity, funding rigorous multiyear research on a condition much of medicine still overlooks.

  • Authority
  • Build
  • Outward
  • Operational

Their shape

The Frontier

At home at the edge of what comes next.

The Frontier is restless and pioneering, always testing what comes next. Its gift is innovation and adaptability, its challenge is focus, and not leaving its longtime members behind.

Also reads toward The Legacy and The Citadel.

Strengths

→You move toward the unknown while others wait for certainty.
→Decisions are made and acted on, and momentum rarely stalls in committee.
→Your field watches you for what's next, not what came before.

Not an official page of Marilyn Brachman Hoffman Foundation. Sociogene does not consult. Everything here comes from public sources, dated and linked. Something wrong here? Tell us what we missed.